Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Fascioliasis: a not rare cause of hypereosinophilia in developing countries, present in developed too

    Gülali Aktaş, İsmail Necati Hakyemez, Abdülkadir Küçükbayrak, Safiye Gürel, Tekin Taş
    e2012029
    2012-05-06
    https://doi.org/10.4084/mjhid.2012.029
    1441
    PDF: 977
    HTML: 6824
  • EARLY PREDICTIVE VALUE OF PERIPHERAL INFLAMMATORY INDEX COMBINED WITH HIGH-SENSITIVITY TROPONIN T FOR SEPSIS-INDUCED CARDIOMYOPATHY Inflammatory and Troponon T in cardiomyopaty from Sepsis

    ChunYan Zong, FeiFeng Wu, FenFen Chen, JiaoJiao Yang, Hong Zhou, BaoFeng Zhu
    e2026045
    2026-04-30
    https://doi.org/10.4084/MJHID.2026.045
    384
    PDF: 397
    HTML: 198
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2638
    PDF: 1785
    HTML: 690
  • EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE LOW-DOSE PRE-PHASE CHEMOTHERAPY IN DIFFUSE LARGE B CELL LYMPHOMA WITH GASTROINTESTINAL INVOLVEMENT

    Luca Guarnera, Federico Meconi, Roberto Secchi, Maria Rosaria Pascale, Fabiana Esposito, Annagiulia Zizzari, Vito Mario Rapisarda, Manuela Rizzo, Livio Pupo, Maria Cantonetti
    e2022017
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.017
    1367
    PDF: 635
    HTML: 454
  • POOR HEMOPOIETIC STEM CELL MOBILIZERS IN MULTIPLE MYELOMA : A SINGLE INSTITUTION EXPERIENCE

    Guillermo Jose Ruiz-Delgado, Avril Lopez-Otero, Ana Hernandez-Arizpe, Aura Ramirez-Medina, Guillermo Jose Ruiz-Argüelles
    e2010016
    2010-06-19
    https://doi.org/10.4084/mjhid.2010.016
    1230
    PDF: 815
    HTML: 598
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2608
    PDF: 1257
    HTML: 1087
  • Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure

    Gloria Joan Morris
    e2012030
    2012-05-06
    https://doi.org/10.4084/mjhid.2012.030
    1311
    PDF: 880
    HTML: 12921
  • OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES

    Jon Salmanton-Garcia, Francesco Marchesi, Oliver A. Cornely, Jannik Stemler, Pierantonio Menna
    2026-02-28
    https://doi.org/10.4084/MJHID.2026.022
    1748
    PDF: 1989
    Suppl. Files: 270
    HTML: 113
  • FACTORS INFLUENCING ADHERENCE TO IMATINIB IN INDIAN CHRONIC MYELOID LEUKEMIA PATIENTS: A CROSS-SECTIONAL STUDY

    Jyotsna Kapoor, Narendra Agrawal, Rayaz Ahmad, Sanjeev Kumar Sharma, Anshul Gupta, Dinesh Bhurani
    e2015013
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.013
    2043
    PDF: 1137
    HTML: 1824
  • CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES

    Ugo Testa, Prof. Patrizia Chiusolo, Dr. Elvira Pelosi, Dr. Germana Castelli, Giuseppe Leone
    e2024031
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.031
    2405
    PDF: 2142
    HTML: 232
  • Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS

    Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc
    e2012018
    2012-03-13
    https://doi.org/10.4084/mjhid.2012.018
    1732
    PDF: 871
    HTML: 1252
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2695
    PDF: 863
    HTML: 5383
  • CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma

    Ugo Testa, Francesco D'Alò, Elvira Pelosi, Germana Castelli, Giuseppe Leone
    e2024012
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.012
    2476
    PDF: 1930
    HTML: 181
  • THE ICET-A RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGEMENT OF DISTURBANCES OF GLUCOSE HOMEOSTASIS IN THALASSEMIA MAJOR PATIENTS

    Vincenzo De Sanctis
    e2016058
    2016-10-25
    https://doi.org/10.4084/mjhid.2016.058
    4328
    PDF: 1288
    HTML: 1430
  • ASSOCIATION OF MYCOBACTERIUM TUBERCULOSIS LINEAGES WITH IFN-? AND TNF-? GENE POLYMORPHISMS AMONG PULMONARY TUBERCULOSIS PATIENT

    Mohammad Varahram, Parissa Farnia, Mohammad Javad Nasiri, Mona Afraei Karahrudi, Mehdi Kazampour, Ali Akbar Velayati
    e2014015
    2014-02-16
    https://doi.org/10.4084/mjhid.2014.015
    1674
    PDF: 998
    HTML: 2227
  • How I treat acute and persistent sickle cell pain

    Samir Ballas
    e2020064
    2020-09-08
    https://doi.org/10.4084/mjhid.2020.064
    2107
    PDF: 1175
    HTML: 771
  • BONE MINERAL DENSITY AND VITAMIN D RECEPTOR GENETIC VARIANTS IN EGYPTIAN CHILDREN WITH BETA THALASSEMIA ON VITAMIN D SUPPLEMENTATION

    Hadeer A Abbassy, Reham Abdel Haleem Abo Elwafa, Omneya Magdy Omar
    e2019013
    2019-01-01
    https://doi.org/10.4084/mjhid.2019.013
    2364
    PDF: 1294
    HTML: 217
  • ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

    Federico Lussana, Alessandro Rambaldi
    e2014065
    2014-10-20
    https://doi.org/10.4084/mjhid.2014.065
    3023
    PDF: 1344
    HTML: 2837
    Figure 1: 214
  • TUBERCULOSIS IN CHILDREN

    Susanna Esposito
    e2013064
    2013-11-04
    https://doi.org/10.4084/mjhid.2013.064
    3300
    PDF: 1394
    HTML: 4921
  • THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA  in TDT

    Vincenzo De Sanctis, Shahina Daar, Ploutarchos Tzoulis, Ashraf Soliman, Ihab Elhakim , Mohammad Faranoush, Christos Kattamis
    e2026055
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.056
    225
    PDF: 228
    HTML: 58
  • FLT3 INTERNAL TANDEM DUPLICATION AND D835 MUTATIONS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA AND ITS CLINICAL SIGNIFICANCE

    Ghaleb Elyamany, Mohamed Awad, Omar Alsuhaibani, Kamal Fadalla, Omer Al Sharif, Mohammad Al Shahrani, Fahad Alabbas, Abdulaziz Al-Abulaaly
    e2014038
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.038
    1942
    PDF: 1027
    HTML: 7311
  • LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASE

    Massimo Breccia, Corrado Girmenia, Roberto Latagliata, Giuseppina Loglisci, Michelina Santopietro, Vincenzo Federico, Luigi Petrucci, Alessandra Serrao, Adriano Salaroli, Giuliana Alimena
    e2011021
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.021
    1797
    PDF: 849
    HTML: 912
    jdoe, table 2 infections CML .doc: 247
    jdoe, table 1 infections CML .doc: 226
  • POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE

    Daniela Capello, Gianluca Gaidano
    e2009018
    https://doi.org/10.4084/mjhid.2009.018
    1432
    PDF: 496
    HTML: 18632
    Figure 1: 201
    Figure 2: 185
    Figure 3: 197
    Figure 4: 230
    Figure 5: 205
  • Bacteraemia Among Patients with Sickle Cell Disease in Nigeria: Association with Spleen Size and Function

    adama isah ladu, Mairo Usman Kadaura, Mohammed Dauda, Abubakar Sadiq Baba, Caroline Jeffery, Abubakar Farate, Adekunle Adekile, Imelda Bates, Russell Dacombe
    e2023054
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.054
    895
    PDF: 564
    HTML: 204
  • DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia

    Buket Altinok Gunes, Yalda Hekmatshoar, Tulin Ozkan, Sureyya Bozkurt, O.Sena Aydos, Yahya Buyukasik, Elifcan Aladag, Asuman Sunguroglu
    e2023008
    2023-01-01
    https://doi.org/10.4084/MJHID.2023.008
    1515
    PDF: 1318
    HTML: 522
  • T-cell Large Granular Lymphocytic Leukemia Manifesting in Patients with HIV-1 Infection: Cases Series and Review of the Literature

    Ashley M Rose, Leidy Isenalumhe, Magali VanDenBergh, Lubomir Sokol
    e2018036
    2018-06-21
    https://doi.org/10.4084/mjhid.2018.036
    2691
    PDF: 992
    HTML: 418
  • Late-onset hepatic veno-occlusive disease after allografting: report of two cases with atypical clinical features successfully treated with defibrotide.

    Alessia Castellino, Stefano Guidi, Chiara Dellacasa, Antonella Gozzini, Irene Donnini, Chiara Nozzoli, Sara Manetta, Semra Aydin, Luisa Giaccone, Moreno Festuccia, Lucia Brunello, Enrico Maffini, Benedetto Bruno, Ezio David, Alessandro Busca
    e2018001
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.001
    4391
    PDF: 1181
    HTML: 1042
  • WHAT ARE FUNGAL INFECTIONS?

    Ben E de Pauw
    e2011001
    2011-01-03
    https://doi.org/10.4084/mjhid.2011.001
    4389
    PDF: 2501
    HTML: 27705
    de Pauw: 281
  • EVOLVING DISEASE SPECTRUM AND CHARACTERISTICS OF PEOPLE WITH HIV IN EASTERN CHINA: A 12-YEAR STUDY

    Ye Xiong, Bohao Dai, Dairong Xiang, Jean-Pierre Routy, Biao Zhu
    e2025077
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.077
    668
    PDF: 297
    Html: 155
  • IDENTİFİCATİON OF LEİSHMANİA TROPİCA FROM PEDİATRİC VİSCERAL LEİSHMANİASİS İN SOUTHERN MEDITERRANEAN REGION OF TURKEY. Molecular characterization of pediatric visceral leishmaniasis

    Derya Alabaz, Fadime Eroğlu, Hüseyin Elçi, Ümmühan Çay
    e2022053
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.053
    1142
    PDF: 765
    HTML: 283
  • MONOCYTE ADHESION MOLECULES EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND LIVER CIRRHOSIS

    Nora E.I. El-Bassiouni, Ola Mahmoud Mahmoud, Eman G El Ahwani, Raafat A. Ibrahim, Azza E.I. El Bassiouny
    e2013054
    2013-09-01
    https://doi.org/10.4084/mjhid.2013.054
    1232
    PDF: 651
    HTML: 1021
  • REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA

    Giovanni D'arena, Giovanni Rossi, Barbara Vannata, Silvia Deaglio
    e2012053
    2012-08-09
    https://doi.org/10.4084/mjhid.2012.053
    2418
    PDF: 1059
    HTML: 7705
    Untitled: 320
    Fig2: 221
    Fig3: 214
    Fig4: 231
  • BRUTON’S TYROSINE KINASE (BTK) MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A CLINICAL VIEW.

    Stefano Molica
    e2025053
    2025-06-29
    https://doi.org/10.4084/MJHID.2025.053
    1869
    PDF: 1043
    HTML: 412
  • DEFERASIROX: OVER A DECADE OF EXPERIENCE IN THALASSEMIA

    Ali Taher
    e2018066
    2018-11-01
    https://doi.org/10.4084/mjhid.2018.066
    3274
    PDF: 1682
    HTML: 375
  • VCAM-1 and ICAM-1 serum levels as markers of relapse in visceral leishmaniasis

    Alexandros Makis, Sophia Tsabouri, Paraskevi Karagouni, Maria Rogalidou, Irene Sionti, Nikolaos Chaliasos
    e2017011
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.011
    4078
    PDF: 852
    HTML: 1561
  • HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

    Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando
    e2021011
    2021-01-01
    https://doi.org/10.4084/mjhid.2021.011
    1788
    PDF: 658
    HTML: 300
  • PLATELET-LEUKOCYTE INTERACTIONS : MULTIPLE LINKS BETWEEN INFLAMMATION , BLOOD COAGULATION AND VASCULAR RISK

    Chiara Cerletti, Giovanni de Gaetano, Roberto Lorenzet
    e2010023
    2010-08-06
    https://doi.org/10.4084/mjhid.2010.023
    1920
    PDF: 942
    HTML: 10558
  • EBV AND HIV-RELATED LYMPHOMA

    Michele Bibas, Andrea Antinori
    e2009032
    2009-12-29
    https://doi.org/10.4084/mjhid.2009.032
    1681
    PDF: 678
    HTML: 7210
  • PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics

    Xiaoqiang Zheng, Hongbing Rui, Ying Liu, Jinfeng Dong
    e2020073
    2020-11-02
    https://doi.org/10.4084/mjhid.2020.073
    896
    PDF: 154
    HTML: 226
  • CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

    guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv
    e2022066
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.066
    1213
    PDF: 704
    HTML: 272
  • Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

    Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez
    e2022013
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.013
    1232
    PDF: 623
    HTML: 244
  • ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION

    Murat Akova
    e2017002
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.002
    4200
    PDF: 1320
    HTML: 2122
    Table 1: 232
  • IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia

    Maja Ružić, Natalija Rajić, Milotka Fabri, Ivana Urošević, Marina Dragičević Jojkić, Tomislav Preveden, Maria Pete, Nebojša Rajić
    e2021058
    2021-08-29
    https://doi.org/10.4084/MJHID.2021.058
    964
    PDF: 445
    HTML: 160
  • Immune thrombocytopenic purpura cases following COVID-19 vaccination.

    Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida
    e2021047
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.047
    1186
    PDF: 487
    HTML: 352
  • Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19

    Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca
    e2020048
    2020-06-28
    https://doi.org/10.4084/mjhid.2020.048
    3294
    PDF: 1935
    HTML: 996
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2651
    PDF: 1040
    HTML: 321
  • CAR-T cells microscopic and phenotypic identification in the peripheral blood CAR-T cells in the PB

    LESESVE
    e2022024
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.024
    1882
    PDF: 727
    HTML: 233
  • THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis

    ANTONIO LEONE, SILVIA MACAGNINO, GIULIA D'AMBRA, DANIELE PERLA
    e2021056
    2021-08-28
    https://doi.org/10.4084/MJHID.2021.056
    1726
    PDF: 614
    HTML: 913
  • PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS

    hend Attia
    e2023046
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.046
    1265
    PDF: 621
    HTML: 250
  • NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms

    Gianfranco Catalano, Pasquale Niscola, Cristina Banella, Daniela Diverio, Malgorzata Monika Trawinska , Stefano Fratoni, Rita Iazzoni, Paolo de Fabritiis, Elisabetta abruzzese, Nelida Ines Noguera
    e2020083
    2020-10-27
    https://doi.org/10.4084/mjhid.2020.083
    1848
    PDF: 1248
    HTML: 354
301 - 350 of 500 items << < 2 3 4 5 6 7 8 9 10 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.